Nicholas Shaheen, M.D., M.P.H.

Professor of Medicine, Chief of the Division of Gastroenterology & Hepatology · UNC at Chapel Hill

Dr. Shaheen's research interest is in the epidemiology and management of esophageal diseases

Epidemiology Esophageal Diseases Reflux Disease Mobility Disorders Barrett's Esophagus

Dr. Sima Salahshor

Adjunct Professor · University of Toronto, Faculty of Medicine

Health Innovation Advisory and Program Design & Management

Pain Management Research Oncology Medical Genetics Health Technologies Health Innovation

Gregg Fields, Ph.D.

Executive Director · Florida Atlantic University

Gregg Fields uses chemistry to answer biological questions, many of which assist in the diagnosis and treatment of major diseases.

Extracellular Matrix Biochemistry Matrix Metalloproteinase Collagen Drug Discovery Protein Biochemistry

James Dahlman

Assistant Professor, Biomedical Engineering · Georgia Tech - COE

James Dahlman uses molecular biology to rationally design the genetic drugs he delivers.

Vascular and Immunoengineering DNA Barcoded Nanoparticles Drug Delivery CRISPR Gene Editing

Craig Earle, MD.

Chief Executive Officer · Canadian Partnership Against Cancer

Dr. Earle leads the transformation of Canada's cancer system as CEO of the Partnership, steward of the Canadian Strategy of Cancer Control

Pan-Canadian Cancer Control Medical Oncology Gastrointestinal Cancers Health Services Research

Jeremy Prokop

Assistant Professor of Pediatrics and Human Development · Michigan State University

The Prokop lab focuses on integrative biosciences for understanding genes and genetic variants.

Pediatrics and Human Development Integrative Biosciences Genes and Genetic Variants

Stephen Frye, Ph.D.

Fred Eshelman Distinguished Professor of Pharmacy & Director, Center for Integrative Biology and Drug Discovery · UNC-Chapel Hill

Stephen Frye is a professor and director of the Center for Integrative Chemical Biology and Drug Discovery.

Chromatin Chemical Biology Medicinal Chemistry Drug Discovery Oncology

John Srigley, MD

Expert Advisor, Pathology · Canadian Partnership Against Cancer

A consultant and educator in oncologic and urologic pathology revolutionizing the understanding of pathologists' role in cancer control

Quality assurance in pathology and synoptic reporting Oncologic Pathology Clinicopathologic and prognostic factor analysis of urologic tumours The classification of genitourinary neoplasia